Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Completed 4Terminated 1No longer available 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 5Expanded_access 1

Sponsor

Cancer Type

CNS 6Sarcoma 3

Conditions

Glioblastoma 4Gliosarcoma 3Brain Neoplasms 3Neoplasms 2Glioma 2Recurrence 1Brain Stem Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
rindopepimut × Clear all
NCT01058850 2021-09-27

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

Stanford University

Phase 1 Terminated
3 enrolled
CNS

Brain Neoplasms, Brain Stem Neoplasms

NCT01498328 2020-02-17

ReACT

Celldex Therapeutics

Phase 2 Completed
127 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT00458601 2018-01-16

ACT III

Celldex Therapeutics

Phase 2 Completed
82 enrolled
CNS

Glioma

NCT01480479 2018-01-16

ACT IV

Celldex Therapeutics

Phase 3 Completed
745 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

NCT03068650 2017-10-18

CDX-110

Celldex Therapeutics

No longer available
CNS

Glioblastoma

NCT00626015 2016-01-21

ZAP IT

Duke University

Phase 1 Completed
16 enrolled
CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡